Aptiva Medical has acquired VeraMed Health to expand its patient base and enhance its leadership in the continuous glucose monitoring market.
Information on the Target
Aptiva Medical, based in Fort Lauderdale, Florida, is a premier provider of continuous glucose monitoring (CGM) systems across the United States. The company has established itself as a leader in diabetes management solutions, offering comprehensive patient support that includes prescription coordination, insurance billing, and home delivery of medical supplies. With a commitment to improving patient outcomes, Aptiva Medical collaborates with healthcare providers and payors to enhance adherence to treatment protocols.
The recent acquisition of VeraMed Health significantly broadens Aptiva Medical's patient base and fortifies its existing referral and payor networks. This strategic move accelerates the company's growth trajectory and solidifies its position as a dominant player in the CGM distribution sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The continuous glucose monitoring industry in the United States has experienced rapid growth driven by the rising prevalence of diabetes and increasing awareness of the importance of effective disease management. With the CDC estimating that around 34 million
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Fortified Health Security → Latitude Information Security
2026
LPOXY Therapeutics, Inc. → Xeno Biosciences Inc.
2025
Aptiva Medical
invested in
VeraMed Health
in 2025
in a Other deal